Changes of PSA Doubling Time is Associated with Disease Progression in Men with Biochemically Relapsed Prostate Cancer Treated with Intermittent Androgen Deprivation
Researchers at the The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland studied the relationship between the change of PSA doubling time (PSADT) and disease progression during intermittent androgen deprivation (IAD) [...]
Pomegranate and Its Role In PSA Velocity
In 2005 there was a small clinical trial performed at UCLA evaluating pomegranate juice and its ability to control PSA for men with prostate cancer. The trial gave 8 oz. of POM Wonderful pomegranate juice [...]
Status Update on the Budget and It’s Implications for Cancer Research
As of now, Congress and the Administration are at an impasse on FY 11 spending. If no deal is reached by Friday, government operations will shut down. This would impact cancer research and prevention programs [...]
Dendreon Gets FDA Approval for Extra Work Stations at their New Jersey Factory
On March 10th (my birthday) Dendreon announced that it has obtained clearance of its new work stations from the FDA. The result of this clearance is the quadrupling the output from the New Jersey factory [...]
Update On the Status of Funding for the DoD for fiscal 2011
There has been some movement in the House of Representatives pertaining to the issue of future funding for the Department of Defense Prostate Cancer Research Program (DoD). The budget debate continues to slog on. We [...]
Carboplatin – A 2nd line chemotherapy?
Carboplatin is a chemotherapy agent used for treatment of many types of cancer. Currently, it is approved by the Food & Drug Administration (FDA) for treating patients with ovarian and non-small cell lung cancer. However, [...]